In oral cancer, ANLN activation leads to phosphorylation of PI3K, mTOR, AKT, and PDK-1, resulting in markedly elevated pathway activity that promotes tumor development (Wang B. et al., 2021). The gene discussed is ANLN; the disease is neoplasm.